XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net loss $ (56,339) $ (869) $ (139,688)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Stock-based compensation 40,683 60,541 69,531
Amortization of intangible assets 34,839 43,376 57,752
Depreciation of property and equipment 13,426 12,638 16,645
Gain from divestitures 0 (100,833) 0
Deferred income taxes 2,255 (2,933) (8,596)
Accrued interest income from note receivable (2,226) (2,026) 0
Accretion of discount from deferred consideration from divestitures (1,678) (1,061) 0
Loss from deconsolidation of Perceive subsidiary 0 4,839 0
Impairment of long-lived assets 0 1,535 1,710
Other 4,938 1,225 748
Changes in operating assets and liabilities:      
Accounts receivable (586) (5,496) 5,721
Unbilled contracts receivable (18,016) (46,315) (19,386)
Prepaid expenses and other assets 6,494 11,071 2,696
Accounts payable (4,695) (3,041) 5,071
Accrued and other liabilities (5,937) (25,325) 3,688
Deferred revenue (13,673) (2,666) 4,170
Net cash (used in) provided by operating activities (515) (55,340) 62
Cash flows from investing activities:      
Capitalized internal-use software (15,593) (11,715) (5,933)
Purchases of property and equipment (5,384) (5,043) (6,815)
Purchases of intangible assets (7) (195) (185)
Net proceeds from divestitures 0 67,773 0
Net cash (used in) provided by investing activities (20,984) 50,820 (12,933)
Cash flows from financing activities:      
Repayment of short-term debt (50,000) 0 0
Withholding taxes related to net share settlement of equity awards (6,966) (7,215) (4,875)
Payment of debt issuance costs (1,249) 0 0
Repayment of long-term debt (1,100) 0 0
Repurchases of common stock 0 (19,990) 0
Proceeds from long-term debt 41,100 0 0
Proceeds from issuance of common stock under employee stock purchase plan 5,974 7,855 11,927
Net cash (used in) provided by financing activities (12,241) (19,350) 7,052
Effect of exchange rate changes on cash and cash equivalents 0 0 126
Net decrease in cash and cash equivalents (33,740) (23,870) (5,693)
Cash and cash equivalents at beginning of period 130,564 [1] 154,434 [1] 160,127
Cash and cash equivalents at end of period [1] 96,824 130,564 154,434
Reconciliation of cash, cash equivalents and cash classified as held-for-sale to consolidated balance sheets:      
Cash and cash equivalents 96,824 130,564 142,085
Cash and cash equivalents classified as held-for-sale, current (Note 7) 0 0 12,349
Total cash, cash equivalents and cash classified as held-for-sale in consolidated balance sheets [1] 96,824 130,564 154,434
Supplemental disclosure of cash flow information:      
Income taxes paid, net of refunds [2] 13,025 19,122 21,333
Interest paid 2,417 3,008 3,000
Supplemental disclosure of noncash investing and financing activities:      
Note receivable in exchange for consideration from divestiture 0 27,676 0
Deferred consideration from divestiture 0 17,156 0
Property and equipment included in accounts payable 862 516 1,343
Costs capitalized for internal-use software included in accounts payable and accrued liabilities $ 137 $ 414 $ 0
[1] Included $12.3 million of cash and cash equivalents classified as held for sale at December 31, 2023.
[2] Refer to Note 14—Income Taxes for the disaggregation of income taxes paid by jurisdiction, net of refunds received, upon the adoption of Accounting Standards Update (“ASU”) 2023-09 for the year ended December 31, 2025.